Shanghai-based Zai Lab Ltd. appointed Billy Cho CFO.
Cho previously served Citigroup as managing director and head of Asia Healthcare Investment Banking.
Zai Lab is focused on medicines for cancer, autoimmune and infectious diseases for patients in China.
